Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 13 | 2019 | 1130 | 0.340 |
Why?
|
| Hepatitis C | 2 | 2006 | 390 | 0.210 |
Why?
|
| Interleukin-11 | 1 | 2003 | 7 | 0.200 |
Why?
|
| Thrombocytopenia | 1 | 2003 | 221 | 0.170 |
Why?
|
| Tissue and Organ Procurement | 2 | 2020 | 253 | 0.160 |
Why?
|
| Hypertension, Portal | 2 | 2014 | 79 | 0.160 |
Why?
|
| Patient Selection | 2 | 2020 | 723 | 0.150 |
Why?
|
| Alcohol Abstinence | 1 | 2019 | 15 | 0.150 |
Why?
|
| Transplant Recipients | 1 | 2020 | 234 | 0.140 |
Why?
|
| Liver Cirrhosis | 2 | 2003 | 900 | 0.140 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2019 | 61 | 0.140 |
Why?
|
| Organ Transplantation | 1 | 2020 | 172 | 0.140 |
Why?
|
| Tissue Donors | 2 | 2020 | 502 | 0.130 |
Why?
|
| Malnutrition | 1 | 2019 | 156 | 0.130 |
Why?
|
| End Stage Liver Disease | 1 | 2019 | 189 | 0.120 |
Why?
|
| Alcoholism | 1 | 2019 | 246 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 2 | 2014 | 463 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 1160 | 0.100 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 1313 | 0.090 |
Why?
|
| Epoprostenol | 1 | 2006 | 42 | 0.060 |
Why?
|
| Contraindications | 1 | 2006 | 77 | 0.060 |
Why?
|
| Ribavirin | 1 | 2006 | 86 | 0.060 |
Why?
|
| Polyethylene Glycols | 1 | 2006 | 245 | 0.050 |
Why?
|
| Interferon-alpha | 1 | 2006 | 241 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2006 | 422 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 62 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 2003 | 79 | 0.050 |
Why?
|
| Platelet Count | 1 | 2003 | 140 | 0.050 |
Why?
|
| Alanine Transaminase | 1 | 2003 | 156 | 0.050 |
Why?
|
| Leukocyte Count | 1 | 2003 | 248 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2003 | 157 | 0.050 |
Why?
|
| Hepatitis C, Chronic | 1 | 2006 | 367 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2003 | 314 | 0.040 |
Why?
|
| Health Care Rationing | 1 | 2001 | 59 | 0.040 |
Why?
|
| Follow-Up Studies | 5 | 2003 | 5277 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2006 | 812 | 0.040 |
Why?
|
| Graft Survival | 3 | 2014 | 465 | 0.040 |
Why?
|
| Adult | 11 | 2014 | 31666 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2014 | 12937 | 0.040 |
Why?
|
| Eligibility Determination | 1 | 2019 | 36 | 0.040 |
Why?
|
| Lamivudine | 1 | 1998 | 29 | 0.040 |
Why?
|
| Waiting Lists | 1 | 2020 | 242 | 0.040 |
Why?
|
| Jejunoileal Bypass | 1 | 1998 | 4 | 0.040 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 1998 | 33 | 0.040 |
Why?
|
| Middle Aged | 9 | 2014 | 28839 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 1998 | 124 | 0.030 |
Why?
|
| Humans | 16 | 2020 | 131501 | 0.030 |
Why?
|
| Tacrolimus | 1 | 1998 | 104 | 0.030 |
Why?
|
| Cyclosporine | 1 | 1998 | 129 | 0.030 |
Why?
|
| Aftercare | 1 | 2019 | 154 | 0.030 |
Why?
|
| Liver Failure, Acute | 1 | 1999 | 96 | 0.030 |
Why?
|
| Anemia, Aplastic | 1 | 1997 | 62 | 0.030 |
Why?
|
| Hepatitis B | 1 | 1998 | 174 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 1998 | 670 | 0.030 |
Why?
|
| Intestine, Small | 1 | 1998 | 286 | 0.030 |
Why?
|
| Cholangitis, Sclerosing | 1 | 1997 | 75 | 0.030 |
Why?
|
| Time Factors | 4 | 2014 | 6273 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 667 | 0.030 |
Why?
|
| Liver Diseases | 1 | 1998 | 381 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2014 | 192 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2014 | 170 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2014 | 131 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2014 | 201 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 705 | 0.020 |
Why?
|
| Postoperative Complications | 3 | 1998 | 3113 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2001 | 1521 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2014 | 441 | 0.020 |
Why?
|
| Preoperative Care | 2 | 2006 | 356 | 0.020 |
Why?
|
| Male | 7 | 2014 | 65158 | 0.020 |
Why?
|
| Recurrence | 3 | 1998 | 1478 | 0.020 |
Why?
|
| Female | 7 | 2014 | 71086 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2014 | 17648 | 0.020 |
Why?
|
| Liver Function Tests | 2 | 1998 | 97 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 547 | 0.010 |
Why?
|
| Reoperation | 2 | 1998 | 835 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2006 | 828 | 0.010 |
Why?
|
| Cadaver | 1 | 2001 | 120 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2006 | 1344 | 0.010 |
Why?
|
| Adolescent | 4 | 2001 | 20918 | 0.010 |
Why?
|
| Los Angeles | 1 | 1998 | 17 | 0.010 |
Why?
|
| Azathioprine | 1 | 1998 | 37 | 0.010 |
Why?
|
| Hospitals, University | 1 | 1998 | 103 | 0.010 |
Why?
|
| Drug Overdose | 1 | 1999 | 72 | 0.010 |
Why?
|
| Hepatic Encephalopathy | 1 | 1999 | 82 | 0.010 |
Why?
|
| Hyperoxaluria, Primary | 1 | 1998 | 12 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1998 | 159 | 0.010 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 1998 | 41 | 0.010 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 1999 | 76 | 0.010 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 1998 | 43 | 0.010 |
Why?
|
| Hepatolenticular Degeneration | 1 | 1998 | 36 | 0.010 |
Why?
|
| Hemochromatosis | 1 | 1998 | 39 | 0.010 |
Why?
|
| Acetaminophen | 1 | 1999 | 97 | 0.010 |
Why?
|
| Prednisone | 1 | 1998 | 244 | 0.010 |
Why?
|
| Copper | 1 | 1998 | 74 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1997 | 27 | 0.010 |
Why?
|
| Hepatitis B virus | 1 | 1998 | 143 | 0.010 |
Why?
|
| Amyloidosis | 1 | 1998 | 71 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 1998 | 220 | 0.010 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 1997 | 104 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1998 | 301 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1997 | 773 | 0.010 |
Why?
|
| Cholangiocarcinoma | 1 | 1997 | 126 | 0.010 |
Why?
|
| Bile Duct Neoplasms | 1 | 1997 | 131 | 0.010 |
Why?
|
| Virus Replication | 1 | 1998 | 597 | 0.010 |
Why?
|
| Cause of Death | 1 | 1997 | 510 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1998 | 1168 | 0.010 |
Why?
|
| Biopsy | 1 | 1998 | 1249 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1997 | 265 | 0.010 |
Why?
|
| Patient Readmission | 1 | 1997 | 423 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1997 | 1404 | 0.010 |
Why?
|
| Survival Rate | 1 | 1998 | 2149 | 0.010 |
Why?
|
| Child | 3 | 1998 | 26240 | 0.010 |
Why?
|
| Child, Preschool | 2 | 1998 | 15047 | 0.010 |
Why?
|
| Liver | 1 | 1998 | 1795 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1997 | 3452 | 0.000 |
Why?
|
| Incidence | 1 | 1997 | 3344 | 0.000 |
Why?
|
| Aged | 2 | 1998 | 21238 | 0.000 |
Why?
|
| United States | 1 | 1999 | 11794 | 0.000 |
Why?
|